Neurological complications of chronic kidney disease

被引:128
作者
Krishnan, Arun V. [1 ]
Kiernan, Matthew C. [2 ]
机构
[1] Univ New S Wales, Translat Neurosci Facil, Sch Med Sci, Sydney, NSW 2052, Australia
[2] Univ New S Wales, Prince Wales Med Res Inst, Sydney, NSW 2052, Australia
基金
英国医学研究理事会;
关键词
RESTLESS LEGS SYNDROME; CHRONIC-RENAL-FAILURE; PERIPHERAL-NERVE FUNCTION; CARPAL-TUNNEL-SYNDROME; MAINTENANCE HEMODIALYSIS-PATIENTS; MIDDLE MOLECULE HYPOTHESIS; SILENT CEREBRAL INFARCTION; COGNITIVE FUNCTION; DIABETIC-NEUROPATHY; UREMIC NEUROPATHY;
D O I
10.1038/nrneurol.2009.138
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Chronic kidney disease (CKD) is a critical and rapidly growing global health problem. Neurological complications occur in almost all patients with severe CKD, potentially affecting all levels of the nervous system, from the CNS through to the PNS. Cognitive impairment, manifesting typically as a vascular dementia, develops in a considerable proportion of patients on dialysis, and improves with renal transplantation. Patients on dialysis are generally weaker, less active and have reduced exercise capacity compared with healthy individuals. Peripheral neuropathy manifests in almost all such patients, leading to weakness and disability. Better dialysis strategies and dietary modification could improve outcomes of transplantation if implemented before surgery. For patients with autonomic neuropathy, specific treatments, including sildenafil for impotence and midodrine for intradialytic hypotension, are effective and well tolerated. Exercise training programs and carnitine supplementation might be beneficial for neuromuscular complications, and restless legs syndrome in CKD responds to dopaminergic agonists and levadopa treatment. The present Review dissects the pathophysiology of neurological complications related to CKD and highlights the spectrum of therapies currently available.
引用
收藏
页码:542 / 551
页数:10
相关论文
共 141 条
[61]   Sensory nerve excitability and neuropathy in end stage kidney disease [J].
Krishnan, AV ;
Phoon, RKS ;
Pussell, BA ;
Charlesworth, JA ;
Kiernan, MC .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (04) :548-551
[62]   Altered motor nerve excitability in end-stage kidney disease [J].
Krishnan, AV ;
Phoon, RKS ;
Pussell, BA ;
Charlesworth, JA ;
Bostock, H ;
Kiernan, MC .
BRAIN, 2005, 128 :2164-2174
[63]   Chronic kidney disease and cognitive impairment in the elderly: The health, aging, and body composition study [J].
Kurella, M ;
Chertow, GM ;
Fried, LF ;
Cummings, SR ;
Harris, T ;
Simonsick, E ;
Satterfield, S ;
Ayonayon, H ;
Yaffe, K .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (07) :2127-2133
[64]   Cognitive impairment in chronic kidney disease [J].
Kurella, M ;
Chertow, GM ;
Luan, J ;
Yaffe, K .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (11) :1863-1869
[65]   Correlates and outcomes of dementia among dialysis patients: the Dialysis Outcomes and Practice Patterns Study [J].
Kurella, Manjula ;
Mapes, Donna L. ;
Port, Friedrich K. ;
Chertow, Glenn M. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (09) :2543-2548
[66]   Intravenous methylcobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients [J].
Kuwabara, S ;
Nakazawa, R ;
Azuma, N ;
Suzuki, M ;
Miyajima, K ;
Fukutake, T ;
Hattori, T .
INTERNAL MEDICINE, 1999, 38 (06) :472-475
[67]   Neurophysiologic parameters and symptoms in chronic renal failure [J].
Laaksonen, S ;
Metsärinne, K ;
Voipio-Pulkki, LM ;
Falck, B .
MUSCLE & NERVE, 2002, 25 (06) :884-890
[68]   Optimizing therapy of seizures in patients with renal or hepatic dysfunction [J].
Lacerda, Glenda ;
Krummel, Thierry ;
Sabourdy, Cecile ;
Ryvlin, Philippe ;
Hirsch, Edouard .
NEUROLOGY, 2006, 67 (12) :S28-S33
[69]   Small fibre neuropathies [J].
Lauria, G .
CURRENT OPINION IN NEUROLOGY, 2005, 18 (05) :591-597
[70]   ADRENERGIC REGULATION OF BLOOD-PRESSURE IN CHRONIC RENAL-FAILURE [J].
LILLEY, JJ ;
GOLDEN, J ;
STONE, RA .
JOURNAL OF CLINICAL INVESTIGATION, 1976, 57 (05) :1190-1200